Advertisement
Salem Radio Network News Sunday, December 17, 2017

Health

FDA approves AstraZeneca’s asthma drug

(Reuters) – Anglo-Swedish pharmaceutical firm AstraZeneca Plc on Tuesday said the U.S. Food and Drug Administration approved its drug benralizumab, as an add-on treatment for patients with severe asthma aged 12 years and older.

The asthma drug will be marketed under the name Fasenra in the United States.

Fasenra is under regulatory review in the EU, Japan and several other countries, the company said.

Previous
Next
AdvertisementAdvertise with Us
Advertisement
Advertisement

Editorial Cartoons

View More » 15124194053858833xpLHnT4hP

Bob Gorrell
Mon, Dec 4, 2017

Advertisement
Advertisement
Advertisement
X CLOSE